|
1
|
Nirasawa S, Kobayashi D, Tsuji N,
Kuribayashi K and Watanabe N: Diagnostic relevance of overexpressed
Nanog gene in early lung cancers. Oncol Rep. 22:587–591.
2009.PubMed/NCBI
|
|
2
|
Duffy MJ: Role of tumor markers in
patients with solid cancers: a critical review. Eur J Intern Med.
18:175–184. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Esquela-Kerscher A and Slack FJ: OncomiRs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar
|
|
4
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Soejima M, Tsuchiya Y, Egashira K, Kawano
H, Sagawa K and Koda Y: Development and validation of a SYBR Green
I–based real-time polymerase chain reaction method for detection of
haptoglobin gene deletion in clinical materials. Transfusion.
6:1322–1327. 2010.
|
|
6
|
Alam MS, Mohon AN, Mustafa S, Khan WA,
Islam N, Karim MJ, Khanum H, Sullivan DJ Jr and Haque R: Real-time
PCR assay and rapid diagnostic tests for the diagnosis of
clinically suspected malaria patients in Bangladesh. Malar J.
10:1752011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pfaffl MW: A new mathematical model for
relative quantification in real-time RT-PCR. Nucleic Acids Res.
9:e452001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Akobeng AK: Understanding diagnostic tests
3: receiver operating characteristic curves. Acta Paediatr.
5:644–647. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Galasso M, Sandhu SK and Volinia S:
MicroRNA expression signatures in solid malignancies. Cancer J.
3:238–243. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Calin GA, Sevignani C, Dumitru CD, et al:
Human microRNA genes are frequently located at fragile sites and
genomic regions involved in cancers. Proc Natl Acad Sci USA.
101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Farazi TA, Spitzer JI, Morozov P and
Tuschl T: miRNAs in human cancer. J Pathol. 2:102–115. 2011.
View Article : Google Scholar
|
|
12
|
Ambros V: MicroRNA pathways in flies and
worms: growth, death, fat, stress, and timing. Cell. 113:673–676.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, et al: MicroRNA expression profiles classify
human cancers. Nature. 435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Keller A, Leidinger P, Borries A,
Wendschlag A, Wucherpfennig F, Scheffler M, Huwer H, Lenhof HP and
Meese E: miRNAs in lung cancer - studying complex fingerprints in
patient’s blood cells by microarray experiments. BMC Cancer.
9:353–363. 2009.PubMed/NCBI
|
|
15
|
Esquela-Kerscher A, Trang P, Wiggins JF,
Patrawala L, Cheng A, Ford L, Weidhaas JB, Brown D, Bader AG and
Slack FJ: The let-7 microRNA reduces tumor growth in mouse models
of lung cancer. Cell Cycle. 6:759–764. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schetter AJ, Leung SY, Sohn JJ, Zanetti
KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, et al: MicroRNA
expression profiles associated with prognosis and therapeutic
outcome in colon adenocarcinoma. JAMA. 299:425–436. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin
GA, Liu CG, Croce CM and Harris CC: Unique microRNA molecular
profiles in lung cancer diagnosis and prognosis. Cancer Cell.
3:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Roa W, Brunet B, Guo L, Amanie J,
Fairchild A, Gabos Z, Nijjar T, Scrimger R, Yee D and Xing J:
Identification of a new microRNA expression profile as a potential
cancer screening tool. Clin Invest Med. 2:E1242010.PubMed/NCBI
|
|
19
|
Grunnet M and Sorensen JB:
Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung
Cancer. 2:138–143. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Okamura K, Takayama K, Izumi M, Harada T,
Furuyama K and Nakanishi Y: Diagnostic value of CEA and CYFRA 21–1
tumor markers in primary lung cancer. Lung Cancer. 1:45–49.
2013.
|
|
21
|
Li X, Asmitananda T, Gao L, Gai D, Song Z,
Zhang Y, Ren H, Yang T, Chen T and Chen M: Biomarkers in the lung
cancer diagnosis: a clinical perspective. Neoplasma. 5:500–507.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Demler OV, Pencina MJ and D’Agostino RB
Sr: Equivalence of improvement in area under ROC curve and linear
discriminant analysis coefficient under assumption of normality.
Stat Med. 12:1410–1418. 2011.PubMed/NCBI
|
|
23
|
Søreide K: Receiver-operating
characteristic curve analysis in diagnostic, prognostic and
predictive biomarker research. J Clin Pathol. 1:1–5. 2009.
|
